Legal Issues in Companion Diagnostics

On January 23rd, members of the Hogan Lovells Global Regulatory Health Care and FDA practice group will provide an in-depth presentation focused on Companion Diagnostics (CDx). The program...

HHS anti-kickback and Stark proposed rules: Impact on value-based care and longstanding regulatory hurdles

CMS and OIG proposed wide-ranging protections for value-based arrangements and provided guidance on a number of regulatory challenges under the AKS and Stark Law. On November 14, join us...

Boston Compliance Forum 2019

The Hogan Lovells Boston team along with regional and international colleagues is hosting an informative breakfast forum in Cambridge, MA on October 29, 2019. The event features two...

Proposed AKS rewrite on drug rebates: The impact and challenges ahead

The Trump Administration recently proposed what is arguably the most sweeping change to the regulatory safe harbors for the federal health care anti-kickback statute in decades. The...

Loading data